A Study of VLX1570 and Dexamethasone in Myeloma Patients

Clinical trial NCT02372240 · TERMINATED

Trial details

NCT number: NCT02372240
Sponsor: Vivolux AB
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2015-04-08
Primary completion: 2017-05-24
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.